Disc Medicine (IRON) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$62.06
+2.1% on the day
-12.3% over 12 months
52-week range $55.95 – $94.11
Share price and insider trades
IRON closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$121M
Insiders buying0
Insiders selling8
Disc Medicine insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $121M of IRON stock on the open market.
Get emailed when insiders cluster-buy stocks like IRON
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
IRON insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $12.7M | 27 |
| Q2 2026 | — | 0 | $6.0M | 16 |
| Q1 2026 | — | 0 | $3.6M | 15 |
| Q4 2025 | — | 0 | $98.6M | 58 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.7×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Disc Medicine, Inc. insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $121M. 63 of 116 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 15SEC | Kevin BittermanDirector | Sell | 27,136 | $70.11 | $1.9M | -11.5% | — |
| Sep 9SEC | Kevin BittermanDirector | Sell Plan | 912318,866 held (−0%) | $79.96 | $73K | -22.4% | — |
| Sep 9SEC | Kevin BittermanDirector | Sell Plan | 759312,230 held (−0%) | $79.96 | $61K | -22.4% | — |
| Sep 9SEC | Kevin BittermanDirector | Sell Plan | 1813,427 held (−0%) | $79.96 | $1K | -22.4% | — |
| Sep 3SEC | Kevin BittermanDirector | Sell Plan | 26,542322,598 held (−8%) | $80.17 | $2.1M | -22.6% | — |
| Sep 3SEC | Kevin BittermanDirector | Sell Plan | 22,090315,337 held (−7%) | $80.17 | $1.8M | -22.6% | — |
| Sep 3SEC | Kevin BittermanDirector | Sell Plan | 2,810319,778 held (−1%) | $79.98 | $225K | -22.4% | — |
| Sep 3SEC | Kevin BittermanDirector | Sell Plan | 2,339312,989 held (−1%) | $79.98 | $187K | -22.4% | — |
| Sep 3SEC | Kevin BittermanDirector | Sell Plan | 51113,501 held (−4%) | $80.17 | $41K | -22.6% | — |
| Sep 3SEC | Kevin BittermanDirector | Sell Plan | 70349,140 held (−0%) | $79.95 | $6K | -22.4% | — |
| Sep 3SEC | Kevin BittermanDirector | Sell Plan | 58337,427 held (−0%) | $79.95 | $5K | -22.4% | — |
| Sep 3SEC | Kevin BittermanDirector | Sell Plan | 5413,445 held (−0%) | $79.98 | $4K | -22.4% | — |
| Sep 3SEC | Kevin BittermanDirector | Sell Plan | 10322,588 held (−0%) | $80.98 | $810 | -23.4% | — |
| Sep 3SEC | Kevin BittermanDirector | Sell Plan | 9315,328 held (−0%) | $80.98 | $729 | -23.4% | — |
| Sep 3SEC | Kevin BittermanDirector | Sell Plan | 213,499 held (−0%) | $80.98 | $162 | -23.4% | — |
| Sep 3SEC | Kevin BittermanDirector | Sell Plan | 114,012 held (−0%) | $79.95 | $80 | -22.4% | — |
| Aug 26SEC | Jonathan Yen-wen YuCOO | Sell Plan | 8,79654,324 held (−14%) | $83.12 | $731K | -25.3% | — |
| Aug 26SEC | Jonathan Yen-wen YuCOO | Sell Plan | 30054,324 held (−1%) | $82.53 | $25K | -24.8% | — |
| Aug 18SEC | John D QuiselCEO | Sell Plan | 12,712237,952 held (−5%) | $79.20 | $1.0M | -21.6% | — |
| Aug 18SEC | John D QuiselCEO | Sell Plan | 11,888226,064 held (−5%) | $79.84 | $949K | -22.3% | — |
| Aug 18SEC | John D QuiselCEO | Sell Plan | 8,400250,664 held (−3%) | $78.11 | $656K | -20.5% | — |
| Aug 14SEC | Jonathan Yen-wen YuCOO | Sell Plan | 80454,324 held (−1%) | $82.64 | $66K | -24.9% | — |
| Aug 7SEC | Rahul KharaGeneral Counsel | Sell Plan | 5,00052,324 held (−9%) | $80.00 | $400K | -22.4% | — |
| Jul 14SEC | John D QuiselCEO | Sell Plan | 16,896232,464 held (−7%) | $74.95 | $1.3M | -17.2% | — |
| Jul 14SEC | John D QuiselCEO | Sell Plan | 9,704249,360 held (−4%) | $74.27 | $721K | -16.4% | — |
| Jul 14SEC | John D QuiselCEO | Sell Plan | 6,400226,064 held (−3%) | $76.05 | $487K | -18.4% | — |
| Jul 9SEC | Jonathan Yen-wen YuCOO | Sell Plan | 10054,324 held (−0%) | $82.50 | $8K | -24.8% | — |
| Jun 30SEC | Rahul KharaGeneral Counsel | Sell Plan | 1,64952,173 held (−3%) | $75.00 | $124K | -17.3% | — |
| Jun 30SEC | Rahul KharaGeneral Counsel | Sell Plan | 85152,173 held (−2%) | $75.00 | $64K | -17.3% | — |
| Jun 30SEC | Jonathan Yen-wen YuCOO | Sell Plan | 30054,324 held (−1%) | $72.50 | $22K | -14.4% | — |
| Jun 24SEC | Jonathan Yen-wen YuCOO | Sell Plan | 9,70054,324 held (−15%) | $72.66 | $705K | -14.6% | — |
| Jun 23SEC | John D QuiselCEO | Sell Plan | 22,927237,137 held (−9%) | $69.92 | $1.6M | -11.2% | — |
| Jun 23SEC | John D QuiselCEO | Sell Plan | 9,522227,615 held (−4%) | $70.70 | $673K | -12.2% | — |
| Jun 23SEC | Rahul KharaGeneral Counsel | Sell Plan | 5,40054,273 held (−9%) | $69.94 | $378K | -11.3% | — |
| Jun 23SEC | Rahul KharaGeneral Counsel | Sell Plan | 1,60052,673 held (−3%) | $70.73 | $113K | -12.3% | — |
| Jun 23SEC | John D QuiselCEO | Sell Plan | 1,551226,064 held (−1%) | $71.61 | $111K | -13.3% | — |
| Jun 23SEC | Rahul KharaGeneral Counsel | Sell Plan | 50052,173 held (−1%) | $71.62 | $36K | -13.3% | — |
| Jun 18SEC | Jonathan Yen-wen YuCOO | Sell Plan | 11,65161,285 held (−16%) | $68.76 | $801K | -9.7% | — |
| Jun 18SEC | Jonathan Yen-wen YuCOO | Sell Plan | 6,96154,324 held (−11%) | $69.92 | $487K | -11.2% | — |
| Apr 15SEC | Jean M. FranchiCFO | Sell Plan | 6,25764,333 held (−9%) | $69.24 | $433K | -10.4% | — |
| Apr 15SEC | William Jacob SavageChief Medical Officer | Sell Plan | 3,53181,680 held (−4%) | $66.12 | $233K | -6.1% | — |
| Apr 15SEC | William Jacob SavageChief Medical Officer | Sell Plan | 2,20079,480 held (−3%) | $66.81 | $147K | -7.1% | — |
| Apr 15SEC | Jean M. FranchiCFO | Sell Plan | 40070,590 held (−1%) | $69.00 | $28K | -10.1% | — |
| Mar 4SEC | William Jacob SavageChief Medical Officer | Sell Plan | 4,39288,197 held (−5%) | $65.52 | $288K | -5.3% | — |
| Mar 4SEC | William Jacob SavageChief Medical Officer | Sell Plan | 2,98685,211 held (−3%) | $66.41 | $198K | -6.6% | — |
| Feb 27SEC | Jean M. FranchiCFO | Sell Plan | 35370,990 held (−0%) | $69.06 | $24K | -10.1% | — |
| Feb 19SEC | Jean M. FranchiCFO | Sell Plan | 4,07578,424 held (−5%) | $62.86 | $256K | -1.3% | — |
| Feb 19SEC | Jean M. FranchiCFO | Sell Plan | 3,68471,343 held (−5%) | $65.89 | $243K | -5.8% | — |
| Feb 19SEC | Jean M. FranchiCFO | Sell Plan | 3,39775,027 held (−4%) | $65.01 | $221K | -4.5% | — |
| Feb 17SEC | John D QuiselCEO | Sell | 13,264226,064 held (−6%) | $62.86 | $834K | -1.3% | — |
| Feb 17SEC | Pamela StephensonChief Commercial Officer | Sell | 5,53180,998 held (−6%) | $62.86 | $348K | -1.3% | — |
| Feb 17SEC | William Jacob SavageChief Medical Officer | Sell | 3,25692,589 held (−3%) | $62.86 | $205K | -1.3% | — |
| Feb 17SEC | Jonathan Yen-wen YuCOO | Sell | 3,23154,324 held (−6%) | $62.86 | $203K | -1.3% | — |
| Feb 17SEC | Rahul KharaGeneral Counsel | Sell | 2,85352,173 held (−5%) | $62.86 | $179K | -1.3% | — |
| Jan 21SEC | Rahul KharaGeneral Counsel | Sell Plan | 1,00037,793 held (−3%) | $69.74 | $70K | -11.0% | — |
| Jan 5SEC | Rahul KharaGeneral Counsel | Sell Plan | 4,99338,950 held (−11%) | $78.62 | $393K | -21.1% | — |
| Jan 5SEC | Rahul KharaGeneral Counsel | Sell Plan | 1,15737,793 held (−3%) | $79.27 | $92K | -21.7% | — |
| Jan 5SEC | Rahul KharaGeneral Counsel | Sell Plan | 35043,943 held (−1%) | $77.67 | $27K | -20.1% | — |
| Dec 18SEC | Kevin BittermanDirector | Sell | 393349,210 held (−0%) | $91.47 | $36K | -32.2% | — |
| Dec 18SEC | Kevin BittermanDirector | Sell | 213337,485 held (−0%) | $91.47 | $19K | -32.2% | — |
| Dec 18SEC | Kevin BittermanDirector | Sell | 14814,013 held (−1%) | $91.47 | $14K | -32.2% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 35,898349,603 held (−9%) | $91.24 | $3.3M | -32.0% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 28,913389,422 held (−7%) | $91.18 | $2.6M | -31.9% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 18,666337,698 held (−5%) | $91.24 | $1.7M | -32.0% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 16,403425,633 held (−4%) | $92.05 | $1.5M | -32.6% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 14,811358,413 held (−4%) | $91.18 | $1.4M | -31.9% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 14,35914,161 held (−50%) | $91.24 | $1.3M | -32.0% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 11,42730,092 held (−28%) | $91.18 | $1.0M | -31.9% | — |
| Dec 16SEC | William Jacob SavageChief Medical Officer | Sell Plan | 9,15176,002 held (−11%) | $91.44 | $837K | -32.1% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 8,527377,022 held (−2%) | $92.05 | $785K | -32.6% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 7,000 | $91.87 | $643K | -32.4% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 6,57044,430 held (−13%) | $92.05 | $605K | -32.6% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 3,921385,501 held (−1%) | $92.01 | $361K | -32.6% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 3,852421,781 held (−1%) | $92.58 | $357K | -33.0% | — |
| Dec 16SEC | William Jacob SavageChief Medical Officer | Sell Plan | 3,64285,153 held (−4%) | $90.60 | $330K | -31.5% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 3,446418,335 held (−1%) | $93.80 | $323K | -33.8% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 2,049356,364 held (−1%) | $92.01 | $189K | -32.6% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 2,005375,017 held (−1%) | $92.58 | $186K | -33.0% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 1,793373,224 held (−0%) | $93.80 | $168K | -33.8% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 1,57228,520 held (−5%) | $92.01 | $145K | -32.6% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 1,54042,890 held (−3%) | $92.58 | $143K | -33.0% | — |
| Dec 16SEC | Kevin BittermanDirector | Sell | 1,37141,519 held (−3%) | $93.80 | $129K | -33.8% | — |
| Dec 16SEC | William Jacob SavageChief Medical Officer | Sell Plan | 30075,702 held (−0%) | $92.23 | $28K | -32.7% | — |
| Dec 15SEC | John D QuiselCEO | Sell Plan | 16,888171,828 held (−9%) | $93.65 | $1.6M | -33.7% | — |
| Dec 15SEC | John D QuiselCEO | Sell Plan | 16,356188,716 held (−8%) | $92.96 | $1.5M | -33.2% | — |
| Dec 15SEC | John D QuiselCEO | Sell Plan | 4,337205,072 held (−2%) | $92.21 | $400K | -32.7% | — |
| Dec 15SEC | John D QuiselCEO | Sell Plan | 2,419209,409 held (−1%) | $90.97 | $220K | -31.8% | — |
| Nov 13SEC | Jonathan Yen-wen YuCOO | Sell Plan | 9,36048,595 held (−16%) | $85.33 | $799K | -27.3% | — |
| Nov 13SEC | Jonathan Yen-wen YuCOO | Sell Plan | 8,04040,555 held (−17%) | $85.91 | $691K | -27.8% | — |
| Nov 13SEC | Jonathan Yen-wen YuCOO | Sell Plan | 8,01562,540 held (−11%) | $83.15 | $666K | -25.4% | — |
| Nov 13SEC | Jonathan Yen-wen YuCOO | Sell Plan | 4,58557,955 held (−7%) | $83.99 | $385K | -26.1% | — |
| Oct 24SEC | Ai Dmi Llc10% Owner | Sell | 744,0472,814,379 held (−21%) | $80.47 | $59.9M | -22.9% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 19,542481,079 held (−4%) | $77.16 | $1.5M | -19.6% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 13,014454,831 held (−3%) | $88.91 | $1.2M | -30.2% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 13,014398,345 held (−3%) | $88.91 | $1.2M | -30.2% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 10,095385,999 held (−3%) | $90.66 | $915K | -31.5% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 10,094442,486 held (−2%) | $90.66 | $915K | -31.5% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 5,066467,845 held (−1%) | $87.37 | $443K | -29.0% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 5,065411,359 held (−1%) | $87.37 | $443K | -29.0% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 3,000472,911 held (−1%) | $86.13 | $258K | -27.9% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 3,000416,424 held (−1%) | $86.13 | $258K | -27.9% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 2,618478,461 held (−1%) | $77.76 | $204K | -20.2% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 2,251452,580 held (−0%) | $89.70 | $202K | -30.8% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 2,251396,094 held (−1%) | $89.70 | $202K | -30.8% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 1,425477,036 held (−0%) | $77.11 | $110K | -19.5% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 1,125475,911 held (−0%) | $84.89 | $96K | -26.9% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 1,125419,424 held (−0%) | $84.89 | $96K | -26.9% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 450442,036 held (−0%) | $91.88 | $41K | -32.5% | — |
| Oct 17SEC | Kevin BittermanDirector | Sell | 450385,549 held (−0%) | $91.88 | $41K | -32.5% | — |
| Oct 9SEC | Kevin BittermanDirector | Sell | 25,400526,577 held (−5%) | $70.54 | $1.8M | -12.0% | — |
| Oct 9SEC | Kevin BittermanDirector | Sell | 13,267500,621 held (−3%) | $72.39 | $960K | -14.3% | — |
| Oct 9SEC | Kevin BittermanDirector | Sell | 12,689513,888 held (−2%) | $71.51 | $907K | -13.2% | — |
| Oct 9SEC | Kevin BittermanDirector | Sell | 12,386551,977 held (−2%) | $69.31 | $858K | -10.5% | — |
| Oct 9SEC | Kevin BittermanDirector | Sell | 11,378579,243 held (−2%) | $68.01 | $774K | -8.7% | — |
| Oct 9SEC | Kevin BittermanDirector | Sell | 8,219564,363 held (−1%) | $68.26 | $561K | -9.1% | — |
| Oct 9SEC | Kevin BittermanDirector | Sell | 6,661572,582 held (−1%) | $69.01 | $460K | -10.1% | — |
Insiders at Disc Medicine, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Ai Dmi Llc10% Owner | — | $59.9M | Oct 24, 2025 | — |
| Kevin BittermanDirector | — | $37.7M | Sep 15, 2026 | — |
| John D QuiselCEO | — | $12.0M | Aug 18, 2026 | — |
| Jonathan Yen-wen YuCOO | — | $5.6M | Aug 26, 2026 | — |
| William Jacob SavageChief Medical Officer | — | $2.3M | Apr 15, 2026 | — |
| Rahul KharaGeneral Counsel | — | $1.9M | Aug 7, 2026 | — |
| Jean M. FranchiCFO | — | $1.2M | Apr 15, 2026 | — |
| Pamela StephensonChief Commercial Officer | — | $348K | Feb 17, 2026 | — |
IRON stock: common questions
Are Disc Medicine, Inc. insiders buying IRON stock?
In the past 12 months, 0 insiders reported open-market purchases of IRON worth $0.
Are Disc Medicine, Inc. insiders selling IRON stock?
8 insiders reported sales worth $121M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is IRON's 52-week range?
Over the past year IRON has traded between $55.95 and $94.11. It last closed at $62.06 on Oct 9, 2026.